[ad_1]
It is true that many studies, researches, discoveries and inventions were revealed in 2018. But it is no secret that the course of science depends on its accumulation, and that the promising medical stages of the year in courses may require new experiences. If effective solutions are found, academic institutions must adopt their own projects to produce a drug at an appropriate price, treating millions of patients around the world.
Vaccine against cancer
This year, researchers at Stanford University announced the development of a vaccine that can eliminate cancerous tumors. This vaccine has been tested in cancer mice and has successfully eliminated cancerous tumors in the animal.
If it works for humans, treating the critical illness will be easier. Cancer chemotherapy currently affects the immune system and many patients experience serious side effects.
"In the context of cancer, the US Food and Drug Administration (FDA) has approved the world's first drug capable of treating any type of cancer, from its source to its origin," said the author and researcher. Study, Ronald Levy. The new drug, called Vitrakvi, is used to treat genetic mutations of cancerous tumors, regardless of the type or location of the disease.
Cultivate an exceptional face
In 2018, French surgeons performed an exciting "medical miracle" by performing a second transplant of the same patient, whose name was not revealed. He had a facial transplant seven years ago, but his body refused to transplant it in a strong and surprising way. In the 1940s, two months in the faceless hospital, the doctors put coma in a coma after removing the "first face" until finding a suitable donor for the second face. The operation took a full day. Doctors will not be able to tell if the operation worked or not, a few weeks ago.
Facial implants are very rare, with only about 40 operations done so far. Patients must continue to take drugs that inhibit the immune system, so that their body does not reject the intruder. The side effects of these drugs make patients susceptible to infections and cancer.
Medications protect against heart attacks
In the United States alone, an estimated 610,000 people die each year from heart attacks, prompting a company to develop a drug called Vacepa, which can reduce the risk of heart attack to 25%.
It is available on prescription and is available to people on a low-fat diet, such as those with high cholesterol. The FDA approved the drug in 2015, but this year's trial has proven effective in reducing some of the harmful fats in the body.
Boshra for migraine sufferers
In the absence of any effective migraine treatment, called "migraine", in May 2018, the US Food and Drug Administration approved the drug "Aimoving," which requires treatment by administering one injection per month to disrupt certain molecules responsible for pain. Caused by the disease.
This medicine has been tested three times. Patients who received injections reported that their condition had improved significantly and that the number of episodes of the disease had been lower than before.
Culture of the uterus of a deceased donor
In another development, doctors said that a Brazilian woman had given birth after undergoing a uterine transplant from a deceased donor, in the first such case to have been successful. The condition involved delivery of veins from the donor's uterus to the recipient's veins, as well as delivery of arteries, ligaments, and badl channels.
The birth follows the failure of 10 previous cases, in which pregnancies from donations were transferred, at the birth of a live baby. The media has highlighted the importance of this process as it could offer infertile women access to more potential donors.
Contact Lenses for Diabetes
Because diabetics need to be careful about the level of glucose in their blood, the Ulsan Institute for Science and Technology, based in Korea, has developed contact lenses that can help people with the disease.
The prestigious institution said in an official statement that these lenses were based on human tears to monitor the glucose level.
These contact lenses are made of nanostructures, which are very thin not to affect human vision, but these lenses have only been tested on rabbits.
Depression Spray
A company has announced a sprayer model that can be used to treat depression using the drug called ketamine for decades. The researchers conducted an experiment involving 236 people with severe clbadic depression, followed by 236 people.
Experience has shown that those who used a nasal spray at the same time as traditional medications felt a clear improvement in just 4 weeks, unlike those who did not use ketamine vaporizer.
The most important Lebanese achievements
By moving to Lebanon, this year has witnessed a series of the most important medical surgeries and modern treatments unique to our country throughout the region, proving each year that it was about the world. East Hospital.
Laparoscopic operation without cranial opening
A qualitative change in cranial surgeries was performed in Lebanon, through a laparoscopic operation to remove a tumor of the optic nerve that expanded to the upper orbital incision .
This procedure, the first of its kind performed at the American Medical Center of the American University of Beirut, helped save a child's life and allowed the surgeon to remove tumors located in the brain and at the top of the spine without the need for large incisions or parts of the skull. In the symmetry recovery in a short time and reduce the proportion of pain during recovery.
In the past, to treat this type of tumor, which is part of the cranial tumors, to open a brain surgery trying to push the brain to reach the tumor, this technique has emerged to treat 60 to 70% of benign tumors. bottom of the skull.
At a time when traditional surgery required about 17 hours in the operating room, this period was halved with the intervention of endoscopy.
New hope for intractable heart disease
When a heart patient previously had a complete blockage of the artery, the options for saving his life were not numerous. Today, thanks to medical development, the world has 2% of centers capable of treating these difficult cases and saving the patient, including one in Lebanon.
Previously, open heart surgery was common, but it is now less prevalent with advanced intervention techniques that provide advanced treatments to open completely closed arteries through the skin, called "complex angioplasty."
This intervention is one of the most sophisticated and complex operations requiring the establishment of a specialized team in the specialized unit created to treat complete and intractable cardiac blockages at St. Georges University Hospital. in fact an invitation to join the US International Cardiovascular Record.
Thus, all the cases of the center are registered in the US Global Register and are reviewed by international experts, which is an important incentive to maintain high standards during these highly interoperable processes.
Replace the cross-skin valve
Also in the heart, a new scientific procedure is added to the balance sheet of Lebanese medical achievements: Lebanon has been able to replace the coronary valve to introduce a transverse valve, rather than an open heart surgery.
This procedure is advanced and unique and offers new options for patients unable to tolerate repeated open heart surgery.
The procedure, which took place for the first time in Lebanon, requires the patient to stay five days in hospital, which corresponds to the period required for surgery requiring a heart, while the patient can go the next day at home after the replacement of the valve.
The success of the first uterine transplant
The implantation of the uterus is a unique innovation, under evaluation and development. The success of the first uterine implantation in Lebanon was announced as part of a scientific research program conducted by a Lebanese medical team in collaboration with a specialized Swedish medical team, a glimmer of hope for Lebanon, the Middle East, North Africa and Turkey.
The success of this process has placed Lebanon on the list of 10 countries in the world that give hope to women who are unable to have children.
Stroke treatment
Stroke is one of the most dangerous medical emergencies in the world. In Lebanon, it is thought that it is the second leading cause of death and one of the leading causes of disability.
Lebanon has made a leap forward with the opening of the Medical Center of the US-Lebanese University – Rizk Hospital, as a center for prevention and treatment of stroke, including a comprehensive and homogeneous medical team, advanced equipment and comprehensive guidelines, as well as a raft landing that carries patients from the hospital surface in cooperation with the army and the Red Cross, in order to move the patient quickly to reduce complications especially in light of the traffic congestion seen by Lebanon's highways.
Source link
